Puma Biotechnology Inc (PBYI) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.657 Good afternoon. My name is John, and I will be your conference call operator today. 00:00:04.657 -- 00:00:07.961 At this time, all participants are in a listen-only mode. 00:00:07.961 -- 00:00:12.026 After the speaker's formal remarks, there will be a question and answer session. 00:00:12.026 -- 00:00:15.971 If you would like to ask a question during that time, simply press the star key, then 00:00:15.971 -- 00:00:20.516 the number 1 on your telephone keypad. If you would like to withdraw your questions, 00:00:20.516 -- 00:00:26.023 please press star 2. If you should require operator assistance during the conference, 00:00:26.023 -- 00:00:30.824 please press star 0. As a reminder, this call is being recorded. 00:00:30.824 -- 00:00:36.152 And I would now like to turn the conference call over to Marian Ohannesson, Senior Director 00:00:36.152 -- 00:00:41.780 of IR for PUMA Biotechnology. Thank you. You may begin your conference. 00:00:41.780 -- 00:00:46.046 Thank you, John. Good afternoon and welcome to PUMA's conference call to discuss our 00:00:46.046 -- 00:00:49.271 results for the first quarter of 2026. Joining 00:00:49.271 -- 00:00:54.057 me on the call today are Ellen Auerbach, Chief Executive Officer, President and Chairman 00:00:54.057 -- 00:00:59.211 of the Board of PUMA Biotechnology, Maximo Noguez, Chief Financial Officer, 00:00:59.211 -- 00:01:04.596 Heather Blaber, Senior Vice President of Marketing, and Roger Storms, Senior Vice President 00:01:04.596 -- 00:01:06.618 of Sales. 00:01:06.618 -- 00:01:10.803 After the close today, PUMA issued a news release detailing results for the first quarter 00:01:10.803 -- 00:01:12.765 of 2026. That 00:01:12.765 -- 00:01:17.770 news release, the slides that Alan and Roger will refer ...